Showing results (21-30 of 100) with videos related to
Sort By:
Pageof 10
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
Inhibitors for metastasis developmentKerstin Lang, Theodore L Drell, Kurt S Zaenker, et al.Current Pharmaceutical Design|October 25, 2014
Anti-metastatics: an overview of drug candidates in current pipelinesAnne Schaap-Nutt, Dane A Thyssen, David W Drell, et al.Cell Communication and Signaling : CCS|July 15, 2010
PC-3 prostate carcinoma cells release signal substances that influence the migratory activity of cells in the tumor's microenvironmentMelanie J Voss, Bernd Niggemann, Kurt S Zänker, et al.Annals of the New York Academy of Sciences|January 15, 2005
Inhibition of cell migration via G protein-coupled receptors to opioid peptides and angiotensinFrank Entschladen, Philipp Bastian, Bernd Niggemann, et al.Immunology Letters|December 23, 2003
Neurotransmitters regulate the migration and cytotoxicity in natural killer cellsKerstin Lang, Theodore L Drell, Bernd Niggemann, et al.Current Pharmaceutical Design|April 24, 2013
Targets for anti-metastatic drug developmentAnna-Maria Stock, Gabriele Troost, Bernd Niggemann, et al.Experimental Cell Research|September 15, 2009
Neutrophil granulocytes promote the migratory activity of MDA-MB-468 human breast carcinoma cells via ICAM-1Carina Strell, Kerstin Lang, Bernd Niggemann, et al.Endocrine-Related Cancer|December 3, 2009
Leptin stimulates the migration of colon carcinoma cells by multiple signaling pathwaysJanina Ratke, Frank Entschladen, Bernd Niggemann, et al.The Lancet. Oncology|March 31, 2004
Tumour-cell migration, invasion, and metastasis: navigation by neurotransmittersFrank Entschladen, Theodore L Drell, Kerstin Lang, et al.Leukemia Research|May 25, 2010
The selective role of myosin VI in lymphoid leukemia cell migrationJbireal M Ali Jbireal, Carina Strell, Bernd Niggemann, et al.Pageof 10